29.49BMarket Cap-14.78P/E (TTM)
27.750High26.500Low3.71MVolume27.400Open26.600Pre Close100.50MTurnover0.34%Turnover RatioLossP/E (Static)1.10BShares28.95052wk High4.52P/B29.49BFloat Cap10.56052wk Low--Dividend TTM1.10BShs Float151.200Historical High--Dividend LFY4.70%Amplitude10.560Historical Low27.064Avg Price100Lot Size--Div YieldTTM--Div Yield LFY
ZAI LAB Stock Forum
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) has received Orphan Drug Designation (ODD) from the U.S. FDA for ZL-1310, their first-in-class DLL3 antibody-drug conjugate (ADC) designed to treat small cell lung cancer (SCLC). The designation comes after promising results from an ongoing Phase 1a/1b study in patients with previously treated extensive-stage SCL...
No comment yet